Bio Green Med Solution (BGMS) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
18 Jun, 2026Opening remarks and agenda
Meeting called to order at 12:30 P.M. Eastern Time, with board members, senior management, and legal counsel present virtually.
Agenda and rules of procedure were made available to attendees via the virtual portal.
Board and executive committee updates
Two individuals, Dr. Satis Waran Nair Krishnan and Inigo Angel Laurduraj, were nominated for re-election as Class I directors for a three-year term expiring at the 2029 annual meeting.
Shareholder proposals
Three proposals were presented: election of Class I directors, ratification of independent auditors, and advisory approval of executive compensation.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Bio Green Med Solution
- Revenue rose to $1.1M, margins improved, but liquidity concerns and major transactions persist.BGMS
Q2 2026 - Q1 2026 fire safety revenue hit $0.8M, but future viability hinges on new funding.BGMSQ1 2026
- Stockholders will vote virtually on director elections, auditor ratification, and executive pay approval.BGMSProxy filing
- Shareholders will virtually vote on directors, auditor ratification, and executive pay, all recommended for approval.BGMSProxy filing
- Net loss narrowed to $3.0 million in 2025 as fire safety revenue reached $0.7 million.BGMSQ4 2025
- Stockholders will vote on key proposals that could shift control and restructure the company's capital.BGMSProxy Filing
- Shareholders to vote on equity issuances, reverse split, and governance changes to secure funding.BGMSProxy Filing
- FADRA demonstrates durable responses in biomarker-driven cancer trials; PLOGO reformulation underway.BGMSH.C. Wainwright 26th Annual Global Investment Conference 2024
- Lower Q2 loss and R&D spend, but cash runway and compliance risks persist.BGMSQ2 2024